Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A B lymphoblastic leukemia/lymphoma that is associated with DUX4 gene rearrangement.
Biomarker and diagnostic research for B acute lymphoblastic leukemia with DUX4 rearrangement has been reported in the published literature.
No clinical trials have been registered for B acute lymphoblastic leukemia with DUX4 rearrangement.
12 publications have been identified in PubMed for B acute lymphoblastic leukemia with DUX4 rearrangement. Research spans Diagnostic / Biomarker (42%), Epidemiology / Natural History (25%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 5 | 42% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:41 PM UTC
Common questions about B acute lymphoblastic leukemia with DUX4 rearrangement
Disease patterns and progression |
3 |
25% |
Laboratory research | 2 | 17% |
Research summaries | 1 | 8% |
Patient case studies | 1 | 8% |
Lu C (2026). [PMID: 41940951](https://pubmed.ncbi.nlm.nih.gov/41940951/). *Blood*. [Diagnostic / Biomarker]
Moritani K (2025). [PMID: 40734767](https://pubmed.ncbi.nlm.nih.gov/40734767/). *EJHaem*. [Epidemiology / Natural History]
Hidalgo-Gómez G (2025). [PMID: 39843811](https://pubmed.ncbi.nlm.nih.gov/39843811/). *Ann Hematol*. [Diagnostic / Biomarker]
Huang YJ (2025). [PMID: 40132994](https://pubmed.ncbi.nlm.nih.gov/40132994/). *Br J Haematol*. [Diagnostic / Biomarker]
Sreedharanunni S (2025). [PMID: 40186692](https://pubmed.ncbi.nlm.nih.gov/40186692/). *Mol Diagn Ther*. [Basic Science / Preclinical]
Vicente-Garcés C (2025). [PMID: 40159352](https://pubmed.ncbi.nlm.nih.gov/40159352/). *Br J Haematol*. [Diagnostic / Biomarker]
Benjamin M (2025). [PMID: 40449797](https://pubmed.ncbi.nlm.nih.gov/40449797/). *Lab Invest*. [Diagnostic / Biomarker]
Bakewell J (2025). [PMID: 40940582](https://pubmed.ncbi.nlm.nih.gov/40940582/). *Leukemia*. [Review / Meta-Analysis]
Kovach AE (2024). [PMID: 38637852](https://pubmed.ncbi.nlm.nih.gov/38637852/). *Pediatr Blood Cancer*. [Epidemiology / Natural History]
Yoshimura S (2024). [PMID: 39102629](https://pubmed.ncbi.nlm.nih.gov/39102629/). *J Clin Oncol*. [Epidemiology / Natural History]